Maastricht, The Netherlands, 2nd November 2018 – Cristal Therapeutics, a clinical stage pharmaceutical company developing targeted nanomedicines for the treatment of cancer and other diseases with high unmet patient need,…
Maastricht, The Netherlands, 25th October 2018 – Cristal Therapeutics, a clinical stage pharmaceutical company developing unique nanomedicines for the treatment of cancer and other diseases, announced today the first patient…
Growth money for BoneMRI: a single imaging exam to image all human tissues without radiation. Utrecht, October 16th, 2018 – Spin-off company of the UMC Utrecht, MRIguidance has received a…
Na jaren van wetenschappelijk onderzoek in het UMC Utrecht en investering van onder andere ReumaNederland, is de zogeheten kniedistractor nu beschikbaar voor de behandeling van patiënten met ernstige knieartrose onder…
De acht universitair medische centra (umc’s) hebben de ontwikkeling van een nieuwe online versie van de eBROK®, die voldoet aan de actuele wet- en regelgeving en aansluit bij de behoefte…
Do you want your research to reach society? Do you have entrepreneurial plans? Are you wondering about your career after your doctorate? Are you constantly negotiating with your professor? Do…
Santa Monica, USA and Utrecht, the Netherlands, July 19, 2018 — Kite, a Gilead Company (Nasdaq: GILD), and Gadeta B.V., a privately-held company focused on the discovery and development of…
Utrecht, June 21st 2018 – A consortium led by AMT Medical, one of Utrecht Holdings’ portfolio companies, has been awarded a Eurostars grant from the EU. The consortium includes AMT…
After 10 years of fundamental research and applications in projects, Utrecht University computer science researcher Dr. Roland Geraerts and his partner Eric de Wilde are proud to introduce their new…